Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib
Tiziana Servidei(Università Cattolica del Sacro Cuore), Riccardo Riccardi(SANE Mental Health Charity)
Cited by 41
Related Papers
Conduct of phase I trials in children with cancer.
|Journal of Clinical Oncology|1998|93
Effects of epidermal growth factor receptor blockade on ependymoma stem cells <i>in vitro</i> and in orthotopic mouse models
|International Journal of Cancer|2011|20